Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial
Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial
Authors of this article:
Lilian Bot1, 2
;
Josine G van Mill1, 2
;
Laetitia J C A Smarius1, 2
;
Adriaan W Hoogendoorn1, 3
;
Bram W C Storosum4
;
Christiaan H Vinkers1, 2, 3, 5
;
Gabriel E Jacobs6, 7
;
Gert Jan Lammers8, 9
;
Hanna M Heller1
;
Jantine C A Colen-de Koning10
;
Joris J B van der Vlugt11
;
Marloes S Oudijn1
;
Martijn S van Noorden6
;
Pierre M Bet5, 7, 9, 12
;
Rolf Fronczek8, 9
;
Heleen S van der Heijden1
;
Sjors M M Lange13
;
Ysbrand D van der Werf5, 14
;
Eric R van Exel1, 2
There are currently no tweets available for this article within the specified range.